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ABSTRACT
The spliceosomal protein Prp1 (Prp6/U5-102K)
is necessary for the integrity of pre-catalytic
spliceosomal complexes. We have identified a
novel regulatory function for Prp1. Expression
of mutations in the N-terminus of Prp1 leads to
the accumulation of pre-catalytic spliceosomal
complexes containing the five snRNAs U1, U2, U5
and U4/U6 and pre-mRNAs. The mutations in the
N-terminus, which prevent splicing to occur,
include in vitro and in vivo identified phosphory-
lation sites of Prp4 kinase. These sites are highly
conserved in the human ortholog U5-102K. The
results presented here demonstrate that structural
integrity of the N-terminus is required to mediate a
splicing event, but is not necessary for the assembly
of spliceosomes.
INTRODUCTION
The chemical reactions leading to the removal of introns
from pre-mRNAs and the basic components, including
the ﬁve small nuclear ribonucleoproteinparticles (U1,
U2, U5 and U4/U6 snRNPs) of a spliceosome, are
conserved throughout evolution (1). Two transester-
iﬁcation reactions are catalyzed by this very dynamic
snRNP–protein machinery. A series of conformational
changes is induced to drive a pre-catalytic spliceosome
into catalysis. These conformational changes are impor-
tant for splicing regulation and quality control (2,3).
A spliceosome assembles in vitro on a pre-mRNA in a
step-wise manner. The snRNPs U1 and U2 recognize the
50- and 30-splice sites, respectively, and then a tri-snRNP
consisting of U4/U6.U5 is recruited to build up the
pre-catalytic spliceosomal complex containing the ﬁve U
snRNPs (2). It is not known how a splicing competent
spliceosome bound to its substrate initiates the switch
towards the multiple rearrangements to form a catalytic
complex. However, it has been shown that the
pre-catalytic spliceosome releases U1 and U4 to rearrange
into the catalytic subcomplex containing the snRNAs
U2.U6.U5 (2,4). How assembly and activation of the
spliceosomal machinery occurs in vivo is still a matter of
intense debate (5). It has been suggested that assembly
of spliceosomes in vivo as well might be a stepwise
process (6–8). However, the isolation and characterization
of a spliceosomal complex from the budding yeast
Saccharomyces cerevisiae containing the ﬁve U snRNAs
and most of the known snRNP proteins led to the sugges-
tion that a penta-snRNP (holospliceosome) may assemble
independently of pre-mRNA (9). The results of other
experimental approaches to determine the sequential
order of events in forming a splicing competent spliceo-
some in vivo suggest that the U1 snRNP recognizes
pre-mRNA ﬁrst. However, it cannot be decided whether
in the next step U2 and then a pre-formed tri-snRNP
U4/U6.U5 or a tetra-snRNP U2.U4/U6.U5 is recruited
to the U1 snRNP-pre-mRNA complex (7–11).
Almost nothing is known how and when an assembled
spliceosome is switched on for catalysis in vivo. The
proteins involved in this switch and, particularly, their
speciﬁc function remains unknown. We have shown that
Prp4 kinase and its physiological substrate Prp1 play a
regulatory role in pre-mRNA splicing in ﬁssion yeast
Schizosaccharomyces pombe. This interaction appears to
be conserved throughout eukaryotic organisms, with the
exception of S. cerevisiae (12–14). Mammalian PRP4K
kinase was found associated with spliceosomes and
spliceosomal proteins, including U5-102K the ortholog
of Prp1 (15,16). The ortholog of Prp1 in budding yeast
S. cerevisiae is called Prp6. In S. pombe prp1
+ cannot be
replaced by the S. cerevisiae PRP6 gene and the budding
yeast genome does not encode an ortholog of Prp4 kinase
(17,18).
Prp1/Prp6/U5-102K is a protein consisting of multiple
direct repeats formerly called TPRs (Tetra-trico
Peptide Repeats), which are now listed as HATs (half a
TPR) in databases (Q12381, PRP1_SCHPO; P19735,
PRP6_YEAST; O94906, PRP6_HUMAN). In Prp1 11
HAT repeats are preceded by a 27-kDa domain at the
N-terminus of the protein which does not show similarities
with known motifs. Interestingly, whereas the C-terminus
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organisms, the N-terminus is less conserved.
In S. cerevisiae Prp6 is necessary for the formation
of a stable tri-snRNP U4/U6.U5. It was suggested that
both yeast and human Prp6 (U5-102K) are required
for tri-snRNP integrity, whereas Prp6 and Prp31 are con-
necting the U5 snRNP with the U4/U6 snRNP particle
(19–24).
Prp1 is essential for growth and expressed by a single
gene on chromosome II. Diﬀerent temperature sensitive
(ts) alleles of prp1 accumulate pre-mRNA and the cell
population arrests speciﬁcally either in G1 or in G2
phase of the cell cycle. This phenotype is caused by
point mutations in the C-terminal part (HAT motifs) of
Prp1 (12,14,17).
Attempts to study the stepwise assembly of
spliceosomal particles with S. pombe whole-cell extracts
failed, due to the lack of an in vitro splicing system.
These investigations revealed, however, that whole-cell
extract of S. pombe contains minute amounts of
tri-snRNP U4/U6.U5 (25).
Three in vivo derived large spliceosomal complexes from
S. pombe have been isolated and analyzed. First, we have
isolated and analyzed the U1 particle. Unexpectedly, the
U1 snRNP exists as a multimeric 45S particle containing
exclusively snRNA U1 associated with the seven Sm core
proteins and nine U1 speciﬁc proteins (26). Second, based
on the analysis of a 35S complex containing the snRNAs
U2, U5 and U6, it was shown that it consists of a mixture
of activated- and post-catalytic spliceosomal complexes.
These spliceosomal subcomplexes did not contain the
bona ﬁde splicing factors Prp1/Prp6/U5-102K and Prp31
(27–30). Third, a complex associated with Prp1/Prp6/
U5-102K and Prp31 has been isolated and proteomic
analysis of the complex revealed that it contains proteins
expected in a spliceosomal sub-complex containing the
four snRNAs U2, U5 and base paired U4/U6 (31). Prp1
and Prp31 are found associated with large spliceosomal
complexes co-sedimenting in a glycerol gradient in the
range of 30–60S. The spliceosomal complexes sedimenting
in this range appear to be a mixture of pre-catalytic
spliceosomal particles containing the four snRNAs U2,
U5 and U4/U6 as well as complexes containing the
ﬁve snRNAs, including U1. Collectively, these results
indicate that Prp1 and Prp31 are proteins associated
with pre-catalytic spliceosomal particles, but not with
post-catalytic complexes (14,28,30,31).
Based on the observations described earlier, we hypo-
thesized that Prp1 might play a regulatory role in splicing
and is involved in the integrity and activation of
pre-catalytic spliceosomal complexes.
Here, we report that expression of Prp1 carrying muta-
tions in the N-terminus leads to the accumulation of pre-
catalytic spliceosomal complexes containing pre-mRNAs.
Spliceosomal complexes associated with mutant Prp1
appear to stall in a pre-catalytic stage containing all ﬁve
snRNPs U1, U2, U5 and U4/U6. The results presented
here indicate that mutations in the N-terminus of Prp1
prevent activation, but not assembly of pre-catalytic
spliceosomes.
MATERIALS AND METHODS
Schizosaccharomyce pombe strains, growth media and
in vivo tagging
Standard genetic and molecular techniques were used as
described earlier (14). Strains were crossed and grown in
media as described (32). All genotypes of the strains used
in this study are listed in Table 1.
For construction of strain 425, prp1 was fused to the
thiamine-repressible nmt1-8 promotor by cloning the prp1
cDNA into the vector pRIP81 (33,34). The nmt1-8
promotor, prp1 cDNA and nmt1-8 termination sequence
were subsequently cloned as a cassette into the plasmid
pJK148 (35). This construct (pJK148nmt1-8 prp1) was
linearized and integrated into the leu1 locus by homolo-
gous recombination. Prototrophic transformants were
checked for integration by polymerase chain reaction
(PCR). In transformants, harboring the nmt1-8 controlled
prp1 cDNA, the prp1 locus was disrupted by integration of
the his7 gene, using a construct containing ﬂanking
sequences of 300bp both upstream and downstream of
the prp1 ORF.
To construct a Myc-tagged version of Prp1, we joined
in a pUR19 vector (36) three PCR fragments comprising
the promoter region of prp1, a cassette comprising a
Myc-epitope and a fragment containing the ORF and 30
UTR of prp1. For integration via homologous recombi-
nation into the ura4 locus, the plasmid was linearized
in the ura4 gene and transformed into strain 425
auxotroph for uracil, containing the ura4-294 allele.
Strains expressing epitope tagged versions of Prp31 were
constructed by introducing a CTAP-KanMX6 or
3 HA-Prp31 module by homologous recombination at
the 30- and 50-end of the endogenous locus, respectively
(37,38). Expression of epitope-tagged proteins was
conErmed by immunoblotting using the appropriate
antibodies (39).
Tap tag puriﬁcation of spliceosomal complexes
Prp31-CTAP containing spliceosomal complexes were
puriﬁed from strain 714 as described by Gould et al.
(40) with several modiﬁcations of the protocol (26). Cells
were grown in 5l Edinburgh Minimal Medium (EMM)
at 30 C in absence or presence of 200mM thiamine and
were harvested after 16–18h. The cell pellet ( 30g fresh
wet weight) was frozen in liquid nitrogen and stored at
–80 C until use. As a negative control, strain 497,
expressing Prp31-HA and Myc-Prp1 was cultivated
under the same growth conditions. For protein extract
preparation, cells were disrupted in a bead beater
(BioSpec Products) in 20ml of NP-40 buﬀer (6mM
Na2HPO4, 4mM NaH2PO4, 1% NP-40, 150mM NaCl,
2mM EDTA, 50mM NaF, 4mg/ml leupeptin, 0.1mM
Na3VO4), containing protease inhibitors (1 Complete
Mini EDTA-free, Roche Diagnostics, 1.3mM,
benzamidin, 1mM PMSF) and RNase inhibitor (20mM
vanadyl ribonucleoside complex), prepared after Berger
and Birkenmeier (41). After cell disruption, glass beads
were washed with an additional 20ml of NP–40 buﬀer.
The lysate was cleared by centrifugation at 16000g for
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extract was split into four aliquots of 10ml and placed
into 0.8 4cm chromatography columns (Bio-Rad,
Poly-Prep), each supplied with 300ml bed volume of
IgG-Sepharose beads (GE Healthcare, IgG-Sepharose 6,
Fast Flow) equilibrated in NP-40 buﬀer.
The beads were incubated on a rotating wheel at 4 C for
2h and subsequently washed three times with 10ml of
IPP150 buﬀer (10mM Tris–HCl pH 8.0, 150mM NaCl,
0.1% NP-40) and three times with 1ml of TEV cleavage
buﬀer (10mM Tris–HCl pH 8.0, 150mM NaCl, 0.1%
NP-40, 0.5mM EDTA, 1.0mM DTT). After the last
washing step, the beads were resuspended in 300ml of
TEV cleavage buﬀer. Then 40U recombinant TEV
protease (MoBiTec GmbH, Goettingen) were added
and the beads were incubated on a rotating wheel at
18 C for 3h.
After incubation with TEV protease, about 1300mlo f
the eluate were collected. Three-hundred microliters of the
eluate were mixed with 100ml of 100% TCA and the
precipitated proteins were analyzed by western blotting
and Coomassie staining. To the remaining eluate (about
1000ml) 3ml calmodulin binding buﬀer (10mM Tris–HCl
pH 8.0, 150mM NaCl, 1mM magnesium acetate, 1mM
imidazole, 2mM CaCl2, 0.1% NP-40, 1mM DTT) were
added and incubated with 300ml calmodulin aﬃnity resin
(Stratagene) on a rotating wheel for 1h at 4 C. The beads
were washed with 3ml calmodulin binding buﬀer contain-
ing 0.1% NP-40 and 2ml calmodulin binding buﬀer con-
taining 0.02% NP-40. The resin bound complexes were
eluted either under native conditions by resuspending
the resin in 1000ml calmodulin elution buﬀer (10mM
Tris–HCl pH 8.0, 150mM NaCl, 1mM magnesium
acetate, 1mM imidazole, 2mM CaCl2, 0.02% NP-40,
20mM EGTA, 1mM DTT) or denaturing conditions
using calmodulin elution buﬀer containing 0.1% sodium
dodecyl sulfate (SDS).
About 300ml of the eluate were used for TCA pre-
cipitation. Precipitated proteins were analyzed by
SDS-polyacrylamide gel electrophoresis (PAGE) and sub-
sequent western analysis and/or Coomassie staining.
From the remaining eluate (700ml), RNA was isolated
by phenol/chloroform extraction and ethanol/sodium
acetate precipitation.
Protein extracts
Protein extracts were prepared after a protocol published
by Moreno et al. (39). In brief, cells were harvested and
washed in STOP buﬀer (150mM NaCl, 50mM NaF
10mM EGTA, 1mM NaN3, pH 8.0). The cell pellet was
resuspended in HBbuﬀer (25mM MOPS pH 7.2, 15mM
EGTA, 15mM MgCl2, 150mM NaCl, 60mM
b-glycerophosphate, 1mM DTT, 0.1mM Na3VO4)c o n -
taining protease inhibitors (1 Complete Mini
EDTA-free, Roche Diagnostics, 4mg/ml leupeptin,
1.3mM, benzamidin, 1mM PMSF) and disrupted with
0.3mm glass beads in a bead beater (FP120 FastPrep cell
disrupter; Savant Instruments, Inc.). After centrifugation
(13800g at 4 C) for 15min, the supernatant was frozen in
liquid nitrogen and stored at –80 C until use.
Glycerol gradient centrifugation
About 3.5–7mg of total protein extract was loaded onto
an 11ml 10–30% glycerol gradient in HB buﬀer, and spun
at 24500r.p.m. for 15h at 4 C using a SW-41 rotor
(Beckman). Nineteen 500-ml fractions were collected
manually from top to bottom. Ten microliters of each
fraction were subjected to solution hybridization. 30S
and 50S ribosomal subunits from Escherichia coli were
used to calibrate the gradients.
Solution hybridization of snRNA
Spliceosomal snRNAs were detected by a solution
hybridization assay as described by Li and Brow (42).
The samples were incubated in 50ml SHS buﬀer (50mM
Tris pH 7.5, 150mM NaCl, 1mM EDTA pH 8.0, 0.1%
SDS, 1mg/ml proteinase K) for 30min at 37 C, extracted
with phenol/chloroform/isoamyl alcohol (50:48:2) and
ethanol precipitated. The RNA was hybridized with
0.1pmol [
32P]-labeled oligonucleotides complementary
(c) to U1, U2, U4, U5 and U6 for 30min at 37 C. After
addition of 6 loading buﬀer (50% glycerol, 10mM
EDTA pH 8.0, 0.025% bromophenol blue, 0.025%
xylene cyanol), the RNA was separated on a native
polyacrylamide gel (9%; 30:1 acrylamide/bisacrylamide,
0.5 TBE) with constant power (5W) and temperature
(48 C). Oligonucleotides used: cU1 (1–26) 50-GCTGCA
GAAACTCATGCCA-GGTAAGT-30; cU2 (35–55) 50-G
AACAGATACTACACTTGATC-30; cU4 (71–92) 50-GT
TGGAGCGGTCAGGGTAATAG-30; cU5 (77–107) 50-G
ATTACAAAAAC-TATACAGTCAAATTAGCAC-30;
cU6 (18–40) 50-CTCTGTATCGTTTCAATTTGACC-30.
Reverse transcriptase-PCR
Prior to Reverse transcriptase (RT)-PCR, the RNA
extracted from TAP eluates was treated with RQ1
RNase-free DNase (Promega) in order to eliminate
possible DNA contaminants. Each microgram of RNA
Table 1. Schizosaccharomyces pombe strains used in this study
Strain Genotype
L972 h
 S
425 h
 S leu1-32 int::pJK148nmt1-8 prp1 ura4-294 prp1::his7 his7-366 prp31 int::HA-prp31
470 h
 S leu1-32 int::pJK148nmt1-8 prp1 ura4-294 int::pUR19-MycPrp1 prp1::his7 his7-366 prp31 int::HA-prp31
714 h
 S leu1-32 int::pJK148nmt1-8 prp1 ura4-294 int::pUR19-MycPrp1D227-249 prp1::his7 prp31 int::prp31-CTAP-KanMx6 his7-366
497 h
 S leu1-32 int::pJK148nmt1-8 prp1 ura4-294 int::pUR19-MycPrp1D227-249 prp1::his7 prp31 int::HA-prp31 his7-366
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[40mM Tris–HCl (pH 8.0), 10mM MgSO4 and 10mM
CaCl2]. After incubation for 30min at 37 C, the RQ1
DNase was inactivated by the addition of 2mM EGTA,
pH 8.0 and heating to 65 C for 10min.
The RNA was reverse transcribed, and the cDNA
ampliﬁed with MasterAmp
TM Tth polymerase
(Epicentre) using the ‘single-tube’ protocol according to
the manufacturer’s instructions. In brief, the RNA was
ﬁrst incubated in presence of 1 reaction buﬀer (20mM
NH4SO4, 50mM Tris–HCl pH 9.0), 3mM MgCl2, 400mM
dNTP (each), 1 MasterAmp
TM PCR enhancer, 0.5mM
MnSO4, 0.5mM of forward and reverse primer and 1.25U
MasterAmp
TM Tth polymerase for 20min at 65 C. Then,
the cDNA was ampliﬁed with 18–25 cycles of 94 C for
30s, 54 C for 30s and 72 C for 25s. The PCR products
were separated on a 3% agarose gel using 1 TBE as a
running buﬀer and stained with ethidium bromide.
For ampliﬁcation of the U snRNAs, the following
primers were used: U1F 50-CGGGATCCACTTACCTG
GCATGAGTTTC-30, U1R 50-ACGCGTCGACTGCCC
CAAATGAGGGACG-30, U2F 50-ATATGGATCCAT
TCTCTCTTTGCCTTTTG-30, U2R 50-ATATGTCGAC
ATTCGGCGTCGCTTGCCA-30, U4F 50-ATATGGAT
CCATCTTTGTGCACGGGTATT-30, U4R 50-ATAT
GTCGACAGTTGGTTTCCAAATATTCC-30, U5F
50-ATATGGATCCATAATCCGTCAAAGCACTTT-30,
U5R 50-ATATGTCGACTTTCAAGAAAAAGATTAC
AAAAA-30, U6F 50-ATATGGATCCGATCTTCGGAT
CACTTTGG-30, U6R 50-ATATGTCGACAAAATGGG
TTT-TCTCTCAAT-30.
For ampliﬁcation of transcripts revealing spliced and
unspliced versions of the ribosomal protein genes rpl29
and rps27, the following primers were used: rpl29F 50-A
TGGCCAAGTCGAAGAATCATACTA-30, rpl29R 50-T
TGGTTGCGGCGGAACTTA-30, rps27F 50-TACCCCG
AGCAATTCACTAACA-30, rps27R 50-ACAACGGTTT
GAGCATGAGAGA-30.
Immunoprecipitation
For immunoprecipitation assays, 5mg of monoclonal
antibodies (HA.11, Hiss Diagnostics) bound to protein
A sepharose (Sigma-Aldrich) was incubated with 500ml
of each gradient fraction at 4 C for 2–16h. The immuno-
precipitates were washed two times with 1ml buﬀer con-
taining 150mM NaCl, 10mM Tris–HCl (pH 7.5) and
0.05% NP-40 at 4 C.
For immunoblotting, 50% of the immunoprecipitates
were separated on an SDS-PAGE and transferred onto
Protran nitrocellulose membrane (Whatman) by
semi-dry blotting, according to the manufacturer’s
instructions. After blocking over night with 10% non-fat
milk powder in 1 TBS, the membranes were incubated
with anti-HA antibodies. After washing with 1 TBS, the
membranes were incubated with the HRP-conjugated
anti-mouse antibodies (Amersham Biosciences). Protein
bands were visualized by chemiluminescence (Pierce
SuperSignal West Pico substrate) according to the manu-
facturer’s instructions. To detect snRNA, 50% of the
immunoprecipitates were incubated in 50ml SHS buﬀer
as described earlier.
Expression and puriﬁcation of recombinant Prp4 and Prp1
Prp4 was expressed in E. coli DH5a as a GST fusion
protein by cloning the prp4 cDNA into the plasmid
pGEX-6P-1 (GE Healthcare). For production of
recombinant Prp4, 10ml of an over night pre-culture
were diluted into 500ml of LB medium, incubated for
2h at 37 C and induced with 1mM IPTG for 3h at
37 C. Cells were harvested by centrifugation and washed
with 1 PBS (137mM NaCl; 2.7mM KCl, 4.3mM
Na2HPO4, 1.4mM KH2PO4, pH 7.4). The cell pellet was
frozen in liquid nitrogen and stored at –80 C until use.
Cells were disrupted by sonication (ﬁve pulses of 10s,
100W) in 1.5ml lysis buﬀer (1 TBS, containing 1mg/ml
lysozyme, 30mg/ml RNase A, 30mg/ml DNase I,
1mM PMSF and 1 Complete Mini, EDTA-free
protease inhibitor). After clariﬁcation of the lysate by
centrifugation with 16000g for 20min, 600ml glutathione
sepharose (4B, GE Healthcare) were added and incubated
for 45min at 4 C with agitation. The sedimented
Sepharose beads were washed with 30 bed volumes of
1 PBS containing 1% (v/v) Triton X-100, 1mM DTT;
and with 10 bed volumes GST cleavage-buﬀer (50mM
Tris–HCl pH 7.0, 150mM NaCl, 1mM EDTA, 1mM
DTT). To elute recombinant Prp4, the beads were
treated with 100U PreScission protease (GE Healthcare)
in 600ml GST cleavage-Puﬀer for 4h at 4 C on a rotating
wheel. The eluate was concentrated by ultra ﬁltration
(Vivaspin 0.5ml, 10000 MWCO, Sartorius) and stored
in kinase buﬀer [20mM HEPES-KOH pH 7.4, 3mM
MgCl2, 5% (v/v) glycerol, 0.5mM DTT] at –80 C
until use.
Recombinant His6-Prp1 was expressed in E. coli
M15[pREP4] by cloning the prp1 cDNA into pQE31
(Qiagene). For induction, an over night pre-culture of
50ml was diluted into 500ml LB medium, incubated at
37 C until an OD600 of 0.5 was reached, chilled to 17 C
and incubated for 16h in presence of 1mM IPTG. After
harvesting, cells were washed in sodium phosphate buﬀer
(50mM Na2HPO4, pH 7.4, 300mM NaCl) and lysed by
sonication in lysis buﬀer (50mM Na2HPO4, 300mM
NaCl, 10mM imidazol, 1mg/ml lysozyme, 10mg/ml
RNase A, 10mg/ml DNase I and 1 Complete Mini,
EDTA-free protease inhibitor) as described earlier.
The cleared protein extract was incubated with 2-ml bed
volume Nickel Sepharose (six Fast Flow, GE-Healthcare)
at 4 C and gentle agitation. After a 30-min incubation, the
Nickel Sepharose was placed into a 0.8 4cm chromatog-
raphy column (Poly-Prep, Biorad) and washed with 30ml
each of lysis and wash buﬀer (50mM Na2HPO4 pH 7.4,
300mM NaCl, 20mM imidazole, 1ml/min ﬂow rate).
The protein was eluted with 4-ml elution buﬀer (50mM
Na2HPO4, 300mM NaCl, 250mM imidazol). The eluate
was placed into a dialysis tube (Spectra/Por, MWCO
12-14000) and dialyzed against 360ml of 5mM
HEPES-KOH pH7.4, 150mM NaCl at 4 C with four
changes of the buﬀer.
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For in vitro phosphorylation of Prp1, 2mg of recombinant
His6-Prp1 were mixed with 1mg Prp4 kinase in 20ml buﬀer
containing 20mM HEPES-KOH pH 7.4, 3mM MgCl2,
5% (v/v) glycerol, 0.5mM DTT, 5mCi g[
32P]ATP and
100mM ATP for 30min at 30 C. The reactions were
stopped by the addition of 2 SDS sample buﬀer and
boiling in a water bath. Proteins were separated by
SDS-PAGE and autoradiography.
Phosphopeptide analysis of Prp1
Phosphopeptide analysis was performed after a protocol
published by Van der Geer et al. (43). In brief, in vitro
phosphorylated Prp1 was separated by SDS-PAGE and
transferred onto nitrocellulose. The phosphorylated
band was excised with a scalpel and incubated in
100mM acetic acid and 0.5% PVP at 37 C for 30min.
After removal of the supernatant, the membrane was
rinsed with ddH2O and freshly prepared 50mM
(NH4)2CO3. Then, the membrane was incubated with
150ml of 50mM (NH4)2CO3, containing 0.1mg/ml
chymotrypsin. After 2h of incubation, another 15mlo f
chymotrypsin (1mg/ml) were added and incubation was
continued for 2h. After addition of 300ml ddH2O, the
samples were centrifuged for 5min at 13000r.p.m. in a
tabletop centrifuge. The supernatant was transferred into
a new tube and dried in a vacuum concentrator at 4 C.
The dried peptides were dissolved in 50ml of a formic acid
and 30% hydrogen peroxide mixture (9:1 ratio) and
oxidized on ice for 1h. After addition of 400ml ddH2O,
the samples were dried as earlier. The peptides were rinsed
in 300ml ddH2O and dried once again. The dried peptides
were dissolved in 7.5ml pH 1.9 buﬀer, containing 50ml of
88% formic acid, 156ml 100% acetic acid and 1794ml
ddH2O. Then, aliquots of 0.5ml were spotted onto a
TLC plate (20 20-cm glass-backed, 0.25mm cellulose
without ﬂuorescent indicator, CEL-300 Macherey-Nagel)
and dried with a fan. The plate was moistened with pH 1.9
buﬀer and the peptides separated for 40min with 1000V
at 16 C. After electrophoresis, the peptides were separated
in the second dimension with buﬀer containing 750ml
n-butanol, 500ml pyridine, 150ml 100% acetic acid
and 600ml ddH2O. The phosphorylated peptides were
detected by autoradiography.
RESULTS
Expression of N-terminal deletions in Prp1 leads to
growth arrest
We had strong indications that Prp1 is phosphorylated
in the N-terminal region at threonine residues. The
N-terminus contains 17 threonines within 258 amino
acids upstream of the HAT domains [http://www
.digibib.tu-bs.de/?docid=00001688, (44)]. Therefore, we
started a mutation analysis deleting short regions of
the N-terminus containing threonines and expressed
these mutations in vivo to study their consequences
(Figures 1B and 6A). To be able to express solely the
mutated version of Prp1 we constructed strains containing
two gene copies of prp1. One copy is driven by its natural
promoter and fused with its coding region to a
Myc-epitope tag; the second copy is under the control of
the thiamine repressible promoter nmt1-8 (Figure 1A).
The control strain expresses two wild-type (wt) prp1
genes in medium without thiamine (–Thi). In medium
with thiamine (+Thi), however, the nmt1-8 driven gene
is repressed. This strain grows in both media with the
same growth rate (Figure 1C, open circles and open
squares). The deletion mutations (N) were fused to the
Myc-epitope tag and are driven by the natural promoter,
which is constitutively transcribed. In these strains, the wt
prp1 is driven by the thiamine repressible promoter. All six
mutant strains show in medium –Thi the same growth rate
as the control strain. However, in medium +Thi, when wt
prp1 is repressed and cells express solely Prp1N, all six
strains arrested growth as shown here for the strain
expressing Myc-Prp1227-249 (Figure 1C, –Thi. ﬁlled
circles; +Thi, ﬁlled squares). Under these conditions
(+Thi) no wt Prp1
wt protein (102kDa) can be detected
(Supplementary Figure S1A, lanes 4–6). These results
reveal that the wt allele is dominant over the DN mutant
alleles. It also suggests that structural integrity of the
N-terminal region appears to be crucial for proper
function of Prp1.
Expression of N-terminal deletions of Prp1 causes
accumulation of pre-catalytic spliceosomes
As discussed in the ‘Introduction’ section, we found Prp1
and Prp31 associated with pre-catalytic spliceosomal
complexes co-sedimenting in a glycerol gradient in the
range of 30–60S. Therefore, we compared the sedimenta-
tion proﬁles of Prp31 and Myc-Prp1227–249 in a
glycerol gradient when both prp1 alleles were expressed
(–Thi) with the sedimentation proﬁles of Prp31 and
Myc-Prp1227–249 when cells expressed solely the
mutant Myc-Prp1227–249 (+Thi). This deletion is
proximal to the ﬁrst HAT (HAT1) motif starting from
amino acid position 258 (Figure 6A, arrow). Cell
extracts were isolated from growing (–Thi) and arrested
cells (+Thi; Figure 1C, arrow). The gradient proﬁle of
Prp31 from growing cells expressing both Prp1
wt and
Myc-Prp1227–249 shows, as expected, Prp31 sediment-
ing in the range of 30–60S (Figure 2, Panel: –Thi,
HA-Prp31). Unexpectedly, probing with anti-Myc-
antibodies (aMyc) to detect Myc-Prp1227–249 indicates
that hardly any mutant protein is sedimenting in this
range with Prp31 suggesting that not much of
Myc-Prp1227–249 associates with these pre-catalytic
spliceosomal particles. Curiously, however, full-length
mutant protein Myc-Prp1227–249 is not found sedi-
menting lower than 30S (Figure 2, Panel:  Thi,
Myc-Prp1227–249). By contrast, using extract of
cells expressing solely Myc-Prp1227–249 (+Thi),
the gradient proﬁles show that Prp31 and mutant
Prp1227–249 are co-sedimenting in the range of 30–
60S and some full-length mutant protein Myc-
Prp1227–249 is sedimenting below 30S. This suggests
that the mutant protein Prp1227–249 mainly binds
to Prp31 complexes, if there is no wt Prp1 available
1614 Nucleic Acids Research, 2010,Vol.38, No. 5(Figure 2, Panel: +Thi, HA-Prp31; and Panel: +Thi,
Myc-Prp1227–249). Careful analysis revealed that
full-length Myc-Prp1227–249, which does not associate
with spliceosomal particles, is degraded mainly to cleavage
products of 45kDa sedimenting below 30S (Supplemen-
tary Figure S1A and B). To conﬁrm this observation, we
also expressed C-terminal deletions of HAT domains in
this system and studied their consequences. The deletion
of HAT11, for example, and sole expression of the mutant
protein (Myc-Prp1825–856) cause growth arrest as the
expression of N-terminal deletions. The C-terminal
mutant proteins, however, do not bind to spliceosomal
Figure 1. Strains expressing N-terminal deletions of Prp1. (A) Each strain expresses a prp1
+ gene controlled by the thiamine repressible promoter
nmt1-8 which can be switched oﬀ by adding thiamine to the medium (+Thi). The second gene is fused in frame to an Myc-epitope-tag and driven by
the natural promoter. The N-terminal mutants Myc-Prp1N depicted in (B) are expressed from this gene, respectively. Both genes are integrated into
the genome. (B) N-terminal deletions were generated and six strains were constructed as described (‘Materials and Methods’ section). Numbers relate
to amino acid positions of Prp1 as listed in the databank. The N-terminus of Prp1 contains 258 amino acids followed by 11 HAT motifs (databank
accession no. Q12381). (C) Growth behavior of strain 497 expressing Prp1 and Myc-Prp1227–249 in medium without thiamine (–Thi; ﬁlled circles)
and expressing solely Myc-Prp1227-249 in medium with thiamine (+Thi; ﬁlled squares). Growth behavior of the control strain (470) expressing two
prp1
+ genes in medium without thiamine (open circles) and one prp1
+ gene in medium with thiamine (open squares). In general, after 18h protein
extract was prepared from cultures with (+Thi) and without (–Thi) thiamine (arrow).
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exclusively as 45-kDa cleavage products sedimenting
in the gradient below 30S (Supplementary Figure S1C
and D).
The strains expressing the other N-terminal deletions
show the same remarkable allelic exclusion phenomenon
as the strain expressing Prp1
wt and Prp1227–249. In
addition, in all cases expressing solely Prp1N, growth
arrest correlates with the accumulation of pre-mRNAs
of the genes rpl29, rps27, tbp1 containing one, two and
three introns, respectively (data not shown).
To characterize spliceosomal complexes of these strains
we puriﬁed them by the tandem aﬃnity puriﬁcation (TAP)
method using TAP-tagged Prp31 (26,45). Extracts of cells
expressing both, Prp1
wt and Myc-Prp1227–249, and
extracts of cells expressing solely Myc-Prp1227–224
were used to purify Prp31–TAP complexes. The material
eluted from the ﬁrst (T) and second (C) column, respec-
tively, was separated on SDS-PAGE, immunoblotted and
probed with antibodies against the calmodulin binding
peptide (aTAP) to detect Prp31. Prp31 eluted from the
columns after proteolytic cleavage of the protein A
region revealed the expected size of 63kDa (Figure 3A,
panel –Thi: lanes 3 and 4; panel +Thi: lanes 7 and 8:
Prp31-CM). Probing the western blots with anti-Myc
antibodies (aMyc) shows that puriﬁed Prp31 from
growing cells is not associated with Myc-Prp1227–249
(Figure 3B, panel –Thi: lanes 3 and 4), whereas in arrested
cells, puriﬁed Prp31 is associated with Myc-Prp1227–
249 (Figure 3B, panel +Thi: lanes 7 and 8). However,
probing the western blot with antibodies against Prp1
(aPrp1) shows that puriﬁed complexes of Prp31 from
growing cells are exclusively associated with Prp1
wt
(Figure 3C, panel –Thi: lanes 3 and 4; Supplementary
Figure S1A). This is consistent with the interpretation of
the results received from the gradient analysis presented
earlier. The sedimentation proﬁles of Prp31 and
Prp1227–249 indicated that Prp1227–249 associates
only with Prp31 complexes sedimenting in the range of
30–60S, if no Prp1
wt is available in the cell (Figure 2,
panel +Thi). After aﬃnity puriﬁcation the sedimentation
proﬁle of Prp31 from arrested cells shows that the Prp31
complexes still sediment in the range of 30–60S as
observed with whole-cell extract (Figure 3E, panel:
aTAP, Prp31-CM).
The material eluted from the second aﬃnity step was
also used to isolate RNA. We used RT-PCR to verify the
presence of the U snRNAs in both samples isolated from
growing ( Thi) and arrested cultures (+Thi). The results
of semiquantitative RT-PCR demonstrate that the TAP
puriﬁed Prp31 complexes associated with Prp1227–249
in arrested cells (+Thi) contain signiﬁcantly more U1
snRNA than the Prp31 complexes associated with
Prp1
wt from growing cells (Figure 4A and B, lane 1,
open square).
The RNA isolated from the spliceosomal Prp31
complexes after the second aﬃnity step was also used to
probe for the presence of pre-mRNAs and mature
mRNAs of the ribosomal protein genes rpl29 and rps27,
respectively. The gene rpl29 contains a single intron of
53nt in size, whereas rps27 contains two introns of 38
and 206nt in size, respectively. The results of semi-
quantitative RT-PCR using total RNA of logarithmically
growing cells show that both ribosomal protein genes are
expressed and, particularly, eﬀectively spliced showing no
trace amount of unspliced pre-mRNA (Figure 4D, lanes 5
and 11). In arrested cultures (+Thi) where the Prp31
complexes are associated with Prp1227–249, the results
of semiquantitative RT-PCR show that the TAP puriﬁed
Prp31 complexes contain signiﬁcant amounts of unspliced
rpl29 pre-mRNA and only trace amounts of mature
mRNA (Figure 4D, lane 3), whereas Prp31 complexes
isolated from growing cells ( Thi) contain only trace
amounts of pre-mRNA and mRNA (Figure 4D, lane 1).
In the case of rps27, the Prp31 complexes isolated from
arrested cultures (+Thi) accumulate partially spliced and
spliced pre-mRNAs (Figure 4D, lanes 7 and 9).
Taken together, the observations described above
prompted us to suggest that the sole expression of
Prp1227–249 leads to stalled pre-catalytic spliceosomes
containing pre-mRNAs and consisting of the ﬁve U
snRNPs. Thus, we may expect accumulation of Prp31 in
Figure 2. Distribution of Prp31 and Prp1227–249 in large complexes. Native extracts of the strain expressing HA-Prp31 and the N-terminal
deletion Myc-Prp1227–249 were prepared and separated on a 10–30% glycerol gradient (top fraction 1 to bottom fraction 19). Fractions 1–19 were
separated by SDS-PAGE, immunoblotted and probed with anti-HA antibodies (aHA) and anti-Myc antibodies (aMyc) as indicated to determine in
the gradient the distribution of HA-Prp31 and Myc-Prp1227–249, respectively. Panels –Thi: extract was isolated after 18h in medium without
thiamine; Panels +Thi: extract was isolated after 18h in medium with thiamine. The gradient was calibrated with small (30S) and large (50S)
ribosomal subunits of Escherichia coli.
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quantitated the relative amount of Prp31 in extracts of
growing cells ( Thi) and compared it with the relative
amount of Prp31 measured in extracts of arrested cells
(+Thi). The results revealed that the amount of Prp31 is
2–4-fold increased in arrested cells, indicating that
pre-catalytic spliceosomal particles associated with Prp31
and Prp1227–249 accumulate in these cells (Figure 5A
and B).
To conﬁrm that Prp31 is associated with native
pre-catalytic spliceosomes containing the ﬁve snRNAs,
including basepaired U4/U6, we immunoprecipitated
extracts of cells expressing HA-Prp31 with HA-antibodies
(aHA) and characterized the snRNA composition of the
immunoprecipitates using a solution hybridization assay
that preserved base pairing of U4 and U6 (26,42). When
Prp31 was immunoprecipitated from extracts of growing
( Thi) and arrested (+Thi) cultures, the spliceo-
somal complexes always contained the ﬁve snRNAs
including base paired U4/U6 (Supplementary Figure S2).
This result and the fact that Prp31 always sediments in a
relatively broad range of 30–60S conﬁrm that
spliceosomal particles containing ﬁve snRNAs U1, U2,
U5, U4/U6 exist in vivo in a pool of pre-catalytic
particles of diﬀerent size. The data presented are consis-
tent with the notion that expression of Prp1227–249
leads to the accumulation of pre-catalytic spliceosomal
particles containing the ﬁve snRNAs and pre-mRNA,
indicating that manipulation in the N-terminal region
of Prp1 prevents activation, but not assembly of
spliceosomes.
Phosphorylation sites of Prp4 kinase in the N-terminus
of Prp1
Prp1 is a physiological substrate of Prp4 kinase; there-
fore, we wanted to determine the phosphorylation
sites in Prp1. Prp4 kinase phosphorylates Prp1 in vitro
at threonine residues in the N-terminal domain (44).
The N-terminus of Prp1 contains 17 threonine residues
distributed throughout the 258 amino acids as indicated
(Figure 6A). Since no phosphorylation site sequences of
Prp4 kinase were known, we changed the 17 threonine
Figure 3. Puriﬁcation of Prp31-CTAP. Cell extracts of 5-l cultures were made from a strain expressing Prp31-CTAP and Myc-Prp1227–249 after
18h in medium without (–Thi) and with (+Thi) thiamine, respectively. Protein extract (E, 0.02% of total), ﬂow through (F; material not binding to
the ﬁrst aﬃnity column), eluate from the ﬁrst aﬃnity column IgG-Sepharose after incubation with TEV protease (T, 5% of the eluate) and eluate
from the calmodulin resin after the second aﬃnity step (C, 5% of the eluate) was separated with SDS-PAGE, immunoblotted and probed with the
indicated antibodies. (A) Blot probed with anti-TAP antibodies: aTAP to detect Prp31-CTAP and Prp31-CM. (B) Blot probed with anti-Myc
antibodies: aMyc to detect MycPrp1227–249. (C) Blot probed with anti-Prp1 antibodies: aPrp1 to detect Prp1
wt (wild type) and
MycPrp1227–249. (D) Mock, cell extracts were made from a strain expressing HA-Prp31 and Myc-Prp1227–249 after 18h in medium +Thi
and applied consecutively to both columns as described above. Blot probed with anti-HA antibodies: aHA to detect HA-Prp31; and probed with
anti-Myc antibodies: aMyc to detect Myc-Prp1227-249. (E) panel aTAP: distribution of Prp31-CM. The eluate from the ﬁrst aﬃnity column (T)
from extract after 18h in medium +Thi was separated on a 10–30% glycerol gradient (top fraction 1 to bottom fraction 18). Fractions 1–18 were
separated by SDS-PAGE and probed with anti-TAP (aTAP) antibodies. Panel aMyc/aTAP: extract after 18h in medium +Thi was separated on a
glycerol gradient followed by SDS-PAGE and probed with anti-Myc (aMyc) and anti-TAP (aTAP) antibodies to determine the distribution
of Myc-Prp1227–249 and Prp31-CTAP, respectively. The gradient was calibrated with small (30S) and large (50S) ribosomal subunits of
Escherichia coli.
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alanine and produced the mutated Prp1 in bacteria.
Recombinant Prp1 and Prp4 kinase were incubated in a
kinase assay with g[
32P]ATP followed by phosphopeptide
analysis of Prp1. The phosphopeptide map of Prp1
wt
revealed three strongly labeled spots and several weak
signals (Figure 6B, panel: wt Prp1, spots 1–3). When we
used a Prp1 protein in which the threonine at position 244
was changed to an alanine (T244A-Prp1), for example,
spot 2 disappears in the peptide map, demonstrating
that position 244 was phosphorylated (Figure 6B, panel:
T244A). The results of the mapping analyses show that
positions T197/199, T205/207, T232/236 and T244 are
unequivocally in vitro phosphorylation sites of Prp4
kinase in the N-terminus of Prp1 (Figure 6B). These
sites are located proximal to the ﬁrst HAT domain,
whereas T232, T236 and T244 reside in the region
which has been deleted in Myc-Prp1227–249 and
T197/199, T205/207 reside in the region deleted in
Myc-Prp1170-208 (Figures 6A and 1B).
Thealignmentoftheaminoacidsequencescomprising50
amino acids of the N-terminus proximal to the ﬁrst HAT
motif (HAT1) of Prp1 with human Prp6, and with
orthologs of genetic model organisms, including
S. cerevisiae, shows that the phosphorylation sites in
this region (amino acids 227–249) are conserved in all
organisms except in the N-terminus of Prp6 of S. cerevisiae
(Figure6C).Itisnoteworthyherethatinphosphoproteome
analysis of ﬁssion yeast a phosphopeptide was detec-
ted which carried a modiﬁed serine at position 235 [Figure
6C, dagger, (46)]. Furthermore, even more intriguingly,
phosphoproteome analysis of human cells revealed
peptides phosphorylated at position T235, T244 and
S248, respectively (Figure 6C; daggers, hsPrp6, O94906).
Figure 4. RT-PCR analysis to detect snRNA and pre-mRNA in aﬃnity puriﬁed Prp31 complexes. (A, B) RNA was extracted from both eluates
(±Thi) of the calmodulin resin (Figure3A, ±Thi, lane C) and subsequently analyzed by RT-PCR to determine its snRNA content. Relative levels of
the ﬁve snRNAs were determined by using speciﬁc primer pairs amplifying U1, U2, U4, U5 and U6 snRNA as indicated on the top of each panel.
The RT-PCR product of snRNA U1 is marked with an open square (lane 1). (C) Total RNA prepared from a wild-type strain L972 was used as a
positive control. (D) The same RNA samples as in (A) and (B) were analyzed by RT-PCR to determine their (pre)-mRNA content. Speciﬁc primer
pairs were used to amplify (pre)-mRNA of the ribosomal protein genes rpl29 and rps27 as indicated. The exon/intron structure of both genes is
shown to the right. Numbers below indicate intron length in nucleotides for both pre-mRNAs. Numbers to the right indicate expected RT-PCR
product sizes in base pairs. All RNA samples were treated with DNase I to remove possible DNA contaminants prior to reverse transcription.
Complete removal of contaminating DNA was veriﬁed by RNase A treatment of the RNA as indicated (RNase+). RT–PCR products were
separated in 3% agarose gels and stained with ethidiumbromide. Lanes marked with ‘C’: negative control without template using the U1 primer
pair. Lanes M: marker (50-bp ladder); numbers to the left indicate fragment length in base pairs.
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Consequences of the expression of N-terminal mutations
in Prp1: accumulation of spliceosomes containing U1,
U2, U5 and U4/U6
In this study, we investigated the function of the
N-terminus of the S. pombe spliceosomal protein Prp1,
which is the ortholog of S. cerevisiae and human Prp6
(U5-102K). This is the ﬁrst report demonstrating that
the N-terminal region of Prp1 is essential to mediate a
splicing event; however, it is not necessary for assembly
of spliceosomes in vivo. The 11 HAT domains comprising
the C-terminus of Prp1 mediate interaction with other
spliceosomal components. Several genetic interactions,
including extragenic suppressors and synthetic lethal
interactions with prp1, have been found. These studies
yielded temperature-sensitive (ts) prp1 alleles containing
mutations in diﬀerent HAT motifs and established an
epistasis map showing, in addition to Prp4 kinase,
genetic interactions with prp13 (encoding snRNA U4 in
S. pombe, snu4) and other spliceosomal components, such
as Prp6 (Snu13 Sc, 15,5K Hs), Prp5 (Prp46 Sc, PRL1 Hs),
Spp101 (Lin1/Snu40 Sc, U5-55K Hs) and Spp42 (Prp8 Sc,
U5-220K Hs), which is involved in coordinating activities
of several splicing factors at the heart of the spliceosome
(12–14,17,47–51 and Razanau and Ka ¨ ufer, unpublished
data). However, none of these studies revealed a ts allele
of prp1 containing a mutation in the N-terminal region of
the protein.
Therefore, we expressed N-terminal mutations in prp1
in a genetic background which contained a repressible wt
gene. Cells expressing both Prp1
wt and Prp1227–249
grow with the same growth rate as cells expressing two
wt genes (Figure 1C). Under these conditions, almost no
mutant Prp1 associates with the spliceosomal particles
sedimenting between 30 and 60S. Although our data pre-
sented in this report reveal that mutant Prp1 does not
interfere with the function of Prp1
wt and that mutant
Prp1 not associated with spliceosomal particles eventually
becomes degraded, we have no data explaining this phe-
nomenon of extreme allelic exclusion. Therefore, we are
prone to speculate. The observation that the wt Prp1
wt
completely outcompetes the mutant protein is consistent
with the idea that Prp1 is involved in the activation of
spliceosomes. Assuming that pre-mRNA splicing activity
is high in growing cells, one would expect that the level
of splicing competent spliceosomes containing Prp1
wt and
all ﬁve snRNPs is very low. We have made many obser-
vations which indicate that Prp1 plays a special
role in regulating pre-mRNA splicing in ﬁssion yeast.
For example, after depletion of Prp1 by switching
oﬀ the prp1 gene, pre-mRNA accumulates and pre-
spliceosomal complexes containing Prp31 and all ﬁve
snRNAs still exist, although Prp1
wt protein was not
detectable anymore (14).
In this report, we showed that in cells solely expressing
Prp1227–249 the increasing amounts of Prp31 and U1
snRNA correlate with the accumulation of unspliced
pre-mRNA associated with pre-catalytic spliceosomes.
This is an indication that the expression of Prp1227–
249 does not prevent assembly of spliceosomes on
pre-mRNA. We do not know, and cannot probe at this
point, whether a proper or aberrant pre-mRNA splicing
complex is assembled when Prp1227–249 is expressed.
However, our data are consistent with the notion that
expression of Prp1227–249 causes spliceosomes to stall
before activation. Interestingly, all the N-terminal muta-
tions investigated show similar phenotypes, emphasizing
that the N-terminus of Prp1 is crucial for activation of
spliceosomes in vivo.
We determined the phosphorylation sites of Prp4 kinase
in Prp1. The generation of the phosphopeptide maps
revealed that seven threonine residues in the N-terminus
of Prp1 are strongly phosphorylated by Prp4 kinase
in vitro (Figure 6A, asterisks). Our experimental
approach to determine by in vivo labeling and subsequent
phosphopeptide mapping whether the in vitro sites are also
used in vivo was cumbersome and revealed convincing data
only for the threonine residue at position 244 (Figure 6C
and data not shown). However, phospho-proteomic
Figure 5. The amount of Prp31 associated with large pre-catalytic
particles increases in cells expressing solely Myc-Prp1227–249.
(A) Protein extract from cells cultured 18 hours in medium without
(–Thi) and with (+Thi) thiamine, respectively, was separated by
SDS-PAGE, immunoblotted and probed with anti-HA antibodies
(aHA), anti-Myc antibodies (aMyc) and anti-Atb2 antibodies (aAtb2)
as indicated. aHA visualizes HA-Prp31, aMyc visualizes Myc-
Prp1227–249 and aAtb2 visualizes Atb2 (a-tubulin). To each lane
10, 20, 40-mg protein extract was applied, respectively. (B) Blots were
analyzed using the Bio-Rad GelDoc XR/ChemiDoc XRS gel documen-
tation system and protein band densities were analyzed using the
Quantity One software provided with the image Station. White
columns relative amount of HA-Prp31 in cells cultured in medium
 Thi; gray columns relative amount of HA-Prp31 in cells cultured in
medium +Thi; 10, 20 and 40mg protein was used as indicated in (A).
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identiﬁed phosphates at the amino acid residues in posi-
tions 235, 244 and 248, indicating that these amino acids
are phosphorylated in vivo. Together, these ﬁndings led us
suggest that this region is a target of kinases, including
Prp4. Most intriguingly, this region, including the posi-
tions of the phosphorylation sites, is highly conserved
throughout the kingdoms with the remarkable exception
of Prp6 of S. cerevisiae (including all Hemiascomycetes,
Figure 6C).
We still do not know what the molecular consequences
are, when Prp1 is phosphorylated by Prp4 kinase in vivo.
However, based on our results presented here and before,
we hypothesize that in ﬁssion yeast phosphorylation of
Prp1 by Prp4 kinase is part of the process in which
spliceosomes are activated (13).
In an elegant study demonstrating that rem1 encoding a
meiotic cyclin is only expressed when a 87-nt intron is
spliced out, it has been shown that pre-mRNA splicing
is coupled with transcription in ﬁssion yeast. Splicing
of rem1-pre-mRNA is dependent on the meiosis speciﬁc
transcription factor Mei4 regulating transcription of the
rem1 gene and recruiting the splicing machinery to the
transcribed locus (52–54). This is one of the very few
examples of pre-mRNA splicing regulation in ﬁssion
yeast so far. However, in ﬁssion yeast about 45% of the
genes contain introns. Genes contain from one to more
than 10 introns and the introns are small with a mean size
of 78nt (55). Thus, we reason that in general removal of
introns in ﬁssion yeast is constitutive by default and, if
splicing is coupled with transcription the spliceo-
somes need to be activated at transcribed loci after the
splicing apparatus has recognized the introns to be
spliced out. We suggest that phosphorylation of Prp1 by
Prp4 kinase plays a role within the described scenario—
either the phosphorylation by Prp4 kinase is part of a
mechanism that signals that an intron is occupied by a
splicing competent spliceosome in a sense of quality
control and/or the phosphorylation is directly involved
in inducing the rearrangements for catalysis. In any
case, our hypothesis can be experimentally approached
and further analysis will help to provide insight into
the complex control mechanisms exerted to express
intron-containing genes.
Figure 6. In vitro and in vivo phosphorylation of Prp1. (A) Deduced
amino acid sequence of the N-terminus of Prp1. Arrow indicates the
beginning of the HAT1 motif (accession no. Q12381). Enlarged T,
threonine; asterisks, threonines phosphorylated in vitro by Prp4
kinase. Underlined sequences are the deleted sequences as schematically
shown in Figure 1B. (B) Phosphopetide maps of Prp1. In an in vitro
kinase assay recombinant Prp1 was incubated with recombinant Prp4
kinase and g[
32P] ATP. After the reaction, Prp1 was separated from
Prp4 and digested with chymotrypsin. The peptides were separated in
two dimensions on TLC plates (‘Materials and Methods’ section). The
phosphopeptides were visualized by exposure to X-ray ﬁlm for 3 days.
Panel wt: wild type, Prp1wt; panel: T197/195A, Prp1 contains an
alanine instead of a threonine at positions 197 and 195; panel:
T244A, T244A Prp1 contains an alanine in position 244; panel:
T205/207A, T205/207A Prp1 contains alanine in positions 205 and
207; panel: T232/236A, Prp1 contains an alanine in positions 232 and
236; panel: T197/199/205/207/232/236/244A, Prp1 contains an alanine
in positions 197/199/205/207/232/236 and 244. (C) Alignment of the
HAT1 motif and the proximal N-terminal region in Prp1 with
sequences of other model organisms. Clustal W alignment of the
deduced S. pombe (sp) Prp1 protein (Q12381) with deduced proteins
from Homo sapiens (hsPrp6, O94906); Drosophila melanogaster
(dmPrp1, Q9VVU6); Caenorhabditis elegans (CePrp1, Q9GRZ2);
Arabidopsis thaliana (atPrp1, Q9ZT71) and S. cerevisiae (ScPrp6,
P19735). Numbers in line indicate the position of the amino acid in
the protein of the respective organism as listed in the databank.
Phosphorylated amino acids serines and threonines at conserved posi-
tions are boxed. Arrows indicate in vitro phosphorylation sites of Prp4
kinase determined above. Dagger at position 235 indicates a
phosphorylated serine determined in phosphoproteomic analysis of
ﬁssion yeast proteins (Q12381). Daggers at position 235, 244 and 248
indicate phosphorylated amino acids determined in phosphoproteomic
analysis of human proteins at positions 266, 275 and 279 of hsPrp6
(O94906).
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